Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

Retroperitoneal fibrosis

Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis The Effect and Safety of Tocilizumab Treatment on IRPF A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis Treatment of IgG4-Related Disease With Revlimid and Rituximab A Prospective Cohort Study of IRPF in China Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria National Registry of IRPF in China